Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

PepsiCo forecasts slower revenue growth

(Sharecast News) - Shares in PepsiCo came under pressure on Friday after fourth-quarter revenues missed expectations and the US food and beverage giant forecast slower annual growth. The owner of Pepsi, Lay's and Quaker, among others, posted a 0.5% decline in revenues in the three months to December end, to $27.9bn.

The slide surprised analysts who were expecting a 1.4% rise to $28.4bn.

Adjusted earnings per share came in at $1.78, however, ahead of forecasts for $1.72, as input and freight costs started to ease.

Organic revenues - which strip out the impact of acquisitions and divestitures - rose 4.5%.

But average prices rose 9% during the quarter, weighing on demand. The North American beverage unit reported a 6% fall in volumes, while Frito-Lay North America - which owns Doritos, Cheetos and other snack brands - dropped 2%.

As at 1245 GMT, shares in PepsiCo were down 1% in pre-market trading.

Chief executive Ramon Laguarta said: "We pleased with our results for 2023, as we successfully navigated another year of elevated levels of inflation, macroeconomic volatility, geopolitical tensions and international conflicts.

"We are confident that our businesses will perform well in 2024 in the context of changing marketplace conditions.

"Category growth rates are normalising as consumer behaviours largely revert to pre-pandemic norm and net revenue realisation moderates as inflation pressures are expected to abate."

PepsiCo forecast organic revenue growth of at least 4% in 2024, and core constant currency earnings per share growth of at least 8%.

That compares to previous forecasts for organic revenue growth between 4% and 6%, and EPS growth in the high single digits. Organic revenues grew by 9.5% in 2023 to $91.5bn.

Share this article

Related Sharecast Articles

Goldman Sachs downgrades SSP to 'sell', prefers WH Smith
(Sharecast News) - Goldman Sachs downgraded SSP on Monday to 'sell' from 'neutral' "on a relative basis" as it took a look at European travel concessions.
UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.